cyclohexanol has been researched along with Body Weight in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (16.28) | 18.7374 |
| 1990's | 7 (16.28) | 18.2507 |
| 2000's | 15 (34.88) | 29.6817 |
| 2010's | 14 (32.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alén, F; de Fonseca, FR; de Heras, RG; Gorriti, MÁ; Orio, L; Pozo, MÁ; Ramírez-López, MT | 1 |
| He, J; Hou, J; Kurihara, H; Lin, F; Tian, J; Xing, Y | 1 |
| Alves, G; Falcão, A; Llerena, A; Magalhães, P | 1 |
| Asokan, A; Ball, AR; Hermer, L; Laird, CD; Ormerod, BK | 1 |
| Albuquerque, GS; Araújo, AV; Caldas, GF; Costa, JG; Costa-Silva, JH; Limeira, MM; Menezes, IR; Silva, TG; Silva-Neto, JD; Wanderley, AG | 1 |
| Huang, XF; South, T | 1 |
| Ara, A; Banu, N; Zafir, A | 1 |
| Berrendero, F; Burokas, A; Gispert, JD; Heyne, A; Kiesselbach, C; Maldonado, R; Martín, M; Martín-García, E; Millán, O; Rubí, B | 1 |
| Bini, V; Borcel, E; Castelli, MP; Llorente, R; Loriga, R; Luesu, W; Mateos, B; Viveros, MP | 1 |
| Dalton, VS; Zavitsanou, K | 1 |
| Armario, A; Fuentes, S; Gagliano, H; Llorente-Berzal, A; López-Gallardo, M; Nadal, R; Viveros, MP | 1 |
| Bento, AF; Calixto, JB; Meotti, FC; Passos, GF; Paszcuk, AF; Silva, ES; Simão da Silva, KAB | 1 |
| Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y | 1 |
| Bennett, BL; Friedman, GC; Lim, AK; Ma, FY; Nikolic-Paterson, DJ; Ozols, E; Tesch, GH; Young, MJ | 1 |
| Bello, NT; Coughlin, JW; Guarda, AS; Ladenheim, EE; Moran, TH; Redgrave, GW | 1 |
| Chen, YC; Feng, SF; Shi, TY; Tan, QR; Wang, WN | 1 |
| Brusman-Lovins, L; King, KH; Malhotra, S; McElroy, SL; Welge, JA | 1 |
| Mbaya, P | 1 |
| Haack, M; Hinze-Selch, D; Koethe, D; Kraus, T; Pollmächer, T; Schuld, A | 1 |
| Ambrosio, E; Biscaia, M; Fernández, B; Guaza, C; Marco, EM; Marín, S; Rubio, M; Viveros, MP | 1 |
| Chun, YJ; Hyun, SH; Jeon, TW; Jeong, TC; Jin, CH; Kim, NH; Lee, DW; Lee, ES; Lee, JS; Lee, SK | 1 |
| Allard, P; Behnke, K; Gram, L; Hanson, M; Søgaard, J; Timdahl, K | 1 |
| Borges, KD; Cunha, GM; de Bruin, GS; de Bruin, VM; de Oliveira, RA; dos Santos-Filho, EA; Viana, GS | 1 |
| Apelqvist, G; Bengtsson, F; Kugelberg, FC; Wikell, C | 1 |
| Hillard, CJ; Rademacher, DJ | 1 |
| Feng, Y; Fong, TM; Francis, B; Goulet, MT; Guan, XM; Hagmann, WK; Jewell, JP; Lanza, TJ; Lao, J; Lin, LS; Liu, P; MacIntyre, DE; Marsh, DJ; Qi, H; Rosko, KM; Shah, SK; Shearman, LP; Shen, CP; Strack, AM; Stribling, DS; Tong, X; Van der Ploeg, LH; Wang, J; Xiao, JC; Xu, SS; Yu, H | 1 |
| Alig, L; Alsenz, J; Andjelkovic, M; Bénardeau, A; Bendels, S; Bleicher, K; Bourson, A; David-Pierson, P; Guba, W; Hildbrand, S; Kube, D; Lübbers, T; Mayweg, AV; Narquizian, R; Neidhart, W; Nettekoven, M; Plancher, JM; Rocha, C; Rogers-Evans, M; Röver, S; Schneider, G; Taylor, S; Waldmeier, P | 1 |
| Greener, Y; Youkilis, E | 1 |
| Bell, GD; Clegg, RJ; Ellis, WR; Middleton, B; White, DA | 1 |
| Guelfi, JD; Guichoux, JY; Hackett, D; Magni, G; White, C | 1 |
| Ikeda, H; Odaka, H | 1 |
| Abe, T; Eguchi, H; Igarashi, K; Igarashi, M; Kimura, M; Manaka, H; Sasaki, H; Sugiyama, K; Tominaga, M | 1 |
| Altenburg, SP; da-Silva, VA; Lindsey, CJ; Malheiros, LR; Thomaz, TG | 1 |
| Connor, TJ; Kelly, JP; Leonard, BE; Nolan, Y; Shen, Y | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Kullingsjö, J; Lundmark, J; Wikell, C | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
| Krause, HP; Puls, W | 1 |
| Endo, N; Kudo, Y; Masuda, Y; Murano, T; Okada, N; Yamamoto, H; Yano, I | 1 |
| Atsumi, S; Iinuma, H; Nosaka, C; Umezawa, K | 1 |
| Creasy, DM; Ford, GR; Gray, TJ | 1 |
| Krämer, A; Staudinger, H; Ullrich, V | 1 |
| Hayano, T; Masuda, Y; Murano, T; Yamamoto, H | 1 |
| Imai, A | 1 |
1 review(s) available for cyclohexanol and Body Weight
| Article | Year |
|---|---|
Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers.
Topics: Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biomarkers; Body Weight; Cyclohexanols; Cytochrome P-450 Enzyme System; Genetic Markers; Humans; Kidney Diseases; Liver Diseases; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking; Venlafaxine Hydrochloride | 2014 |
5 trial(s) available for cyclohexanol and Body Weight
| Article | Year |
|---|---|
Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Body Weight; Bulimia; Comorbidity; Cyclohexanols; Female; Humans; Middle Aged; Obesity; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Body Weight; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pulse; Social Behavior; Venlafaxine Hydrochloride | 2002 |
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Body Weight; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Leptin; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2002 |
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Weight; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2004 |
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.
Topics: Adult; Aged; Body Weight; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
37 other study(ies) available for cyclohexanol and Body Weight
| Article | Year |
|---|---|
Increased alcohol consumption in rats after subchronic antidepressant treatment.
Topics: Alcohol Drinking; Alcohols; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Addictive; Body Weight; Conditioning, Operant; Cyclohexanols; Disease Models, Animal; Fluoxetine; Male; Motor Activity; Rats; Rats, Wistar; Self Administration; Time Factors; Venlafaxine Hydrochloride | 2013 |
Gender differences in CMS and the effects of antidepressant venlafaxine in rats.
Topics: Anhedonia; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; Cyclohexanols; Female; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Restraint, Physical; Sex Characteristics; Stress, Psychological; Tacrolimus Binding Proteins; Venlafaxine Hydrochloride | 2013 |
Desvenlafaxine may accelerate neuronal maturation in the dentate gyri of adult male rats.
Topics: Animals; Antidepressive Agents; Biomarkers; Body Weight; Cell Count; Cell Differentiation; Cyclohexanols; Dentate Gyrus; Desvenlafaxine Succinate; Male; Neurogenesis; Pyramidal Cells; Rats | 2014 |
Repeated-doses and reproductive toxicity studies of the monoterpene 1,8-cineole (eucalyptol) in Wistar rats.
Topics: Animals; Anti-Infective Agents; Body Weight; Cyclohexanols; Dose-Response Relationship, Drug; Eucalyptol; Female; Fetus; Humans; Male; Maternal Exposure; Monoterpenes; Organ Size; Pregnancy; Rats; Rats, Wistar; Reproduction; Toxicity Tests | 2016 |
Temporal and site-specific brain alterations in CB1 receptor binding in high fat diet-induced obesity in C57Bl/6 mice.
Topics: Animals; Body Weight; Brain; Cannabinoids; Cyclohexanols; Diet; Dietary Fats; Energy Intake; Humans; Leptin; Male; Mice; Mice, Inbred C57BL; Obesity; Receptor, Cannabinoid, CB1 | 2008 |
Invivo antioxidant status: a putative target of antidepressant action.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Body Weight; Cyclohexanols; Depressive Disorder; Fluvoxamine; Food Preferences; Imipramine; Lipid Peroxidation; Protein Carbonylation; Rats; Restraint, Physical; Stress, Psychological; Swimming; Taste; Venlafaxine Hydrochloride | 2009 |
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
Topics: Amides; Analysis of Variance; Animals; Autoradiography; Benzoxazines; Body Weight; Brain; Cyclohexanols; Diet Fads; Disease Models, Animal; Eating; Female; Guanosine 5'-O-(3-Thiotriphosphate); International Cooperation; Morpholines; Naphthalenes; Obesity; Piperidines; Protein Binding; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Sulfur Isotopes; Time Factors; Tomography Scanners, X-Ray Computed; Tritium; Whole Body Imaging | 2010 |
Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.
Topics: Animals; Autoradiography; Body Weight; Brain; Cyclohexanols; Female; Male; Maze Learning; Memory Disorders; Nicotine; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Sex Characteristics | 2011 |
Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210.
Topics: Age Factors; Analgesics; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Brain; Brain Mapping; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Male; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Tissue Distribution; Tritium | 2010 |
Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour.
Topics: Adrenocorticotropic Hormone; Analgesics; Animals; Arousal; Attention; Behavior, Animal; Body Weight; Cannabinoids; Cyclohexanols; Exploratory Behavior; Female; Hypothalamo-Hypophyseal System; Inhibition, Psychological; Injections, Intraperitoneal; Leptin; Male; Maternal Deprivation; Maze Learning; Motor Activity; Organ Size; Pituitary-Adrenal System; Rats; Rats, Wistar; Risk-Taking; Sensory Gating; Sex Factors | 2011 |
Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits inflammatory and neuropathic persistent pain in mice.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Area Under Curve; Body Weight; Cyclohexanols; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Edema; Enzyme-Linked Immunosorbent Assay; Freezing Reaction, Cataleptic; Hyperalgesia; Inflammation; Locomotion; Male; Mice; Neuralgia; Oleanolic Acid; Oligodeoxyribonucleotides, Antisense; Pain Threshold; Pentacyclic Triterpenes; Peroxidase; Protein Binding; Rats; Rats, Wistar; Receptors, Cannabinoid; Tritium | 2011 |
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Topics: Albuminuria; Animals; Blood Pressure; Body Weight; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Early Medical Intervention; Hypertension; Hypertrophy; Immunohistochemistry; Inhibitory Concentration 50; Male; MAP Kinase Kinase 4; Protein Kinase Inhibitors; Purines; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction | 2011 |
Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density.
Topics: Analysis of Variance; Animals; Autoradiography; Body Weight; Brain; Bulimia; Cannabinoids; Cyclohexanols; Diet; Disease Models, Animal; Eating; Female; Food Deprivation; Food Preferences; Gene Expression Regulation; Genes; Nodose Ganglion; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; RNA, Messenger; Tritium | 2012 |
Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.
Topics: Adrenocorticotropic Hormone; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Blotting, Western; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cyclohexanols; Depression; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Food Preferences; Hydrocortisone; Male; MAP Kinase Signaling System; Motor Activity; Neurogenesis; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2012 |
Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood.
Topics: Analgesics; Analysis of Variance; Animals; Body Weight; Corticosterone; Cyclohexanols; Eating; Female; Growth; Male; Maze Learning; Motor Activity; Rats; Rats, Wistar; Sex Factors; Time Factors | 2003 |
Pretreatment with 1,8-cineole potentiates thioacetamide-induced hepatotoxicity and immunosuppression.
Topics: Alanine Transaminase; Animals; Antibody Formation; Aspartate Aminotransferases; Blotting, Western; Body Weight; Carcinogens; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Synergism; Erythrocytes; Eucalyptol; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mixed Function Oxygenases; Monoterpenes; Organ Size; Rats; Rats, Sprague-Dawley; Sheep; Thioacetamide | 2004 |
The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.
Topics: Animals; Body Weight; Corpus Striatum; Cyclohexanols; Female; Immobilization; Maze Learning; Memory; Motor Activity; Rats; Rats, Wistar; Sleep Deprivation; Venlafaxine Hydrochloride | 2004 |
Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Brain; Cyclohexanols; Liver; Locomotion; Male; Organ Size; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzamides; Body Weight; Cannabinoid Receptor Modulators; Carbamates; Cyclohexanes; Cyclohexanols; Dose-Response Relationship, Drug; Drinking Behavior; Drug Interactions; Endocannabinoids; Food Deprivation; Food Preferences; Male; Mice; Mice, Inbred ICR; Phenols; Piperidines; Pyrazoles; Restraint, Physical; Reward; Rimonabant; Stress, Psychological; Sucrose; Time Factors; Water Deprivation | 2007 |
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
Topics: Amides; Animals; Anti-Obesity Agents; Binding, Competitive; Body Temperature; Body Weight; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Dose-Response Relationship, Drug; Eating; Humans; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Obesity; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Transfection | 2007 |
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.
Topics: Animals; Anti-Obesity Agents; Benzodioxoles; Body Weight; Crystallography, X-Ray; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Humans; Hypothermia; Ligands; Male; Mice; Microsomes; Models, Molecular; Molecular Structure; Obesity; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Structure-Activity Relationship | 2008 |
Assessment of the cataractogenic potential of cyclohexanone in guinea pigs and rabbits.
Topics: Administration, Topical; Animals; Body Weight; Cataract; Cyclohexanes; Cyclohexanols; Cyclohexanones; Female; Glucuronates; Guinea Pigs; Injections, Intravenous; Lens, Crystalline; Male; Rabbits | 1984 |
The effects of 3,5,5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile flow and biliary lipid secretion in the rat.
Topics: Animals; Bile; Body Weight; Cholesterol; Cyclohexanols; Hydroxymethylglutaryl CoA Reductases; Lipid Metabolism; Liver; Male; Phospholipids; Rats; Rats, Inbred Strains | 1984 |
AO-128, alpha-glucosidase inhibitor: antiobesity and antidiabetic actions in genetically obese-diabetic rats, Wistar fatty.
Topics: Animals; Body Weight; Cyclohexanols; Diabetes Mellitus; Eating; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Male; Obesity; Rats; Rats, Wistar | 1995 |
Slight but significant improvement of insulin resistance of Wistar fatty rats by treatment with a disaccharidase inhibitor, AO-128.
Topics: Animals; Blood Glucose; Body Weight; Cyclohexanols; Disaccharidases; Eating; Fasting; Glucose; Glucose Clamp Technique; Glycosuria; Infusions, Intravenous; Insulin; Insulin Resistance; Liver; Rats; Rats, Wistar; Urine | 1997 |
Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Birth Weight; Body Weight; Cyclohexanols; Female; Fluoxetine; Growth; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Weight Gain | 1999 |
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclohexanols; Desipramine; Drinking Behavior; Eating; Endotoxins; Escherichia coli; Interleukin-10; Lipopolysaccharides; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 1999 |
Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Biogenic Monoamines; Body Weight; Cyclohexanols; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Tissue Distribution; Venlafaxine Hydrochloride | 2001 |
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Imipramine; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Neuroimmunomodulation; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2001 |
Delay of carbohydrate absorption by inhibitors of intestinal alpha-glucosidases.
Topics: Amylases; Animals; Blood Glucose; Body Weight; Cyclohexanols; Dietary Carbohydrates; Gastric Mucosa; Insulin; Intestinal Absorption; Intestine, Large; Intestine, Small; Kinetics; Obesity; Oligosaccharides; Rats; Rats, Inbred Strains; Sucrose; Triglycerides; Trisaccharides | 1979 |
Studies on dependence on tramadol in rats.
Topics: Adrenal Cortex; Analgesics; Animals; Behavior, Animal; Body Weight; Cyclohexanols; Drug Tolerance; Female; Humans; Male; Morphine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1978 |
Biological activities of cyclophellitol.
Topics: 1-Deoxynojirimycin; Animals; Anti-Bacterial Agents; beta-Glucosidase; Binding, Competitive; Body Weight; Cell Line; Cyclohexanols; Female; Glucosamine; Glucosylceramidase; Indolizines; Mice; Microsomes; Tumor Cells, Cultured | 1990 |
The morphogenesis of cyclohexylamine-induced testicular atrophy in the rat: in vivo and in vitro studies.
Topics: Aging; Animals; Atrophy; Body Weight; Cells, Cultured; Cyclohexanols; Cyclohexylamines; Male; Morphogenesis; Organ Size; Rats; Rats, Inbred Strains; Reference Values; Seminiferous Tubules; Sertoli Cells; Testis | 1990 |
Effect of n-hexane inhalation on the monooxygenase system in mice liver microsomes.
Topics: Alkanes; Animals; Body Weight; Cyclohexanes; Cyclohexanols; Cytochrome P-450 Enzyme System; Cytochrome Reductases; Cytochromes; Hexanols; Hydroxylation; Mice; Microsomes, Liver; Organ Size; Phenobarbital; Protein Binding; Proteins; Time Factors | 1974 |
Studies on the physical dependence of a new central analgesic; 1-(m-methoxyphenyl)-2-dimethylaminomethyl cyclohexanol (1) HCL (CG-315).
Topics: Adrenal Glands; Alcohols; Analgesics; Animals; Body Weight; Cyclohexanes; Cyclohexanols; Depression, Chemical; Dimethylamines; Drug Tolerance; Female; Humans; Male; Morphine; Organ Size; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1972 |
Fecal flora and cecal weights in mice given validamycin A.
Topics: Amines; Animals; Antifungal Agents; Bacteroides; Body Weight; Cecum; Cyclohexanols; Enterobacteriaceae; Escherichia coli; Feces; Klebsiella; Male; Mice; Organ Size; Penicillin G; Proteus; Staphylococcus; Streptococcus | 1974 |